A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Abb Vie Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 1,348,304 shares of ABBV stock, worth $243 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
1,348,304
Previous 1,521,945 11.41%
Holding current value
$243 Million
Previous $261 Million 2.0%
% of portfolio
1.24%
Previous 1.26%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $28.4 Million - $34.6 Million
-173,641 Reduced 11.41%
1,348,304 $266 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $799,335 - $933,444
-5,164 Reduced 0.34%
1,521,945 $261 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $43.2 Million - $49.2 Million
270,034 Added 21.48%
1,527,109 $278 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $6.49 Million - $7.31 Million
47,201 Added 3.9%
1,257,075 $195 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $48.6 Million - $56.2 Million
363,528 Added 42.95%
1,209,874 $180 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $28.3 Million - $35.2 Million
213,494 Added 33.74%
846,346 $114 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $25.2 Million - $29.1 Million
-174,550 Reduced 21.62%
632,852 $101 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $34.6 Million - $41.5 Million
-250,358 Reduced 23.67%
807,402 $130 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $16.4 Million - $18.8 Million
-122,098 Reduced 10.35%
1,057,760 $142 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $17.8 Million - $22.6 Million
-129,310 Reduced 9.88%
1,179,858 $181 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $16.2 Million - $20.1 Million
-122,586 Reduced 8.56%
1,309,168 $213 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $55 Million - $69.6 Million
512,174 Added 55.7%
1,431,754 $195 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $6.81 Million - $7.73 Million
64,034 Added 7.48%
919,580 $99.3 Million
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $3.94 Million - $4.39 Million
37,490 Added 4.58%
855,546 $96.4 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $9.99 Million - $11 Million
97,620 Added 13.55%
818,056 $88.7 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $296,847 - $400,774
3,688 Added 0.51%
720,436 $77.2 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $4.88 Million - $5.72 Million
56,760 Added 8.6%
716,748 $62.8 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $5.37 Million - $7.19 Million
73,217 Added 12.48%
659,988 $64.8 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $1.45 Million - $2.19 Million
-22,414 Reduced 3.68%
586,771 $44.7 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $57.6 Million - $72.1 Million
-799,090 Reduced 56.74%
609,185 $53.9 Million
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $3.81 Million - $4.58 Million
60,422 Added 4.48%
1,408,275 $107 Million
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $21.9 Million - $28 Million
333,183 Added 32.84%
1,347,853 $98 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $3.87 Million - $4.56 Million
-50,199 Reduced 4.71%
1,014,670 $81.8 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $5.42 Million - $6.68 Million
69,605 Added 6.99%
1,064,869 $98.2 Million
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $1.07 Million - $1.19 Million
-11,990 Reduced 1.19%
995,264 $94.1 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $7.83 Million - $9.26 Million
87,189 Added 9.48%
1,007,254 $93.3 Million
Q1 2018

Apr 30, 2018

SELL
$92.01 - $123.21 $10.1 Million - $13.5 Million
-109,787 Reduced 10.66%
920,065 $87.1 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $8.92 Million - $9.78 Million
-99,610 Reduced 8.82%
1,029,852 $99.6 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $6.27 Million - $8 Million
-89,700 Reduced 7.36%
1,129,462 $100 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,219,162
1,219,162 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.